By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health has established a wholly owned subsidiary focused on providing clinical genetic services to doctors and patients.

In its Form 10-K dated March 14 and filed with the US Securities and Exchange Commission, the Redwood City, Calif.-based firm said the subsidiary, created earlier this month, is called InVitae and will begin offering services in 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.